Alterity Therapeutics Ltd ATHE
Annual
Quarterly
No annual revenue total was found in ALTERITY THERAPEUTICS LTD's SEC filings.
Alterity Therapeutics Ltd (ATHE) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
217.51M
-97.6% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ATHE (Nasdaq), PRNAF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Melbourne
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1131343
- Former names
- PRANA BIOTECHNOLOGY LTD (until Apr 8, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 30, 2026 | Oct 31, 2026 |
| 6-K | Current report (foreign issuer) | Oct 23, 2026 | Oct 31, 2026 |
| 6-K | Current report (foreign issuer) | Oct 23, 2026 | Oct 31, 2026 |
| 6-K | Current report (foreign issuer) | Oct 23, 2026 | Oct 31, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 31, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 31, 2026 |
All 1000 Alterity Therapeutics Ltd SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.